Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
MCN Am J Matern Child Nurs ; 46(5): 271-276, 2021.
Article in English | MEDLINE | ID: mdl-34398828

ABSTRACT

PURPOSE: The purpose of the study was to describe and analyze the experience of women with substance use disorder during pregnancy and parenting to inform health care services that promote recovery. STUDY DESIGN: Interviews of pregnant or parenting women with substance use disorder were used in this qualitative descriptive study. METHODS: Participants were recruited from two recovery centers serving pregnant or parenting women with substance use disorder. Participants called a study cellphone to speak with the researchers about their substance use and recovery. Four independent reviewers conducted thematic analysis and were facilitated by Atlas.ti qualitative analysis program. RESULTS: N = 15 women called the study cellphone; 10 met inclusion criteria and were interviewed. Researchers coded 81 themes with the common occurrence of prior trauma, multiple substances used, stigma and judgment from others, and having children as a motivation to seeking recovery. Co-occurrence of themes of positive social support and the pursuit of recovery was identified. CLINICAL IMPLICATIONS: Positive social support co-occurring with recovery supports the need for strengthened social support structures. Health care professionals should intentionally address the culture of caring for pregnant and parenting women with substance use disorder through education, practice, advocacy, and research.


Subject(s)
Mothers/psychology , Parenting/psychology , Pregnant Women/psychology , Social Support , Substance-Related Disorders/psychology , Child , Female , Health Personnel , Humans , Interviews as Topic , Pregnancy , Qualitative Research , Substance-Related Disorders/nursing
3.
J Perinatol ; 41(6): 1236-1243, 2021 06.
Article in English | MEDLINE | ID: mdl-33589723

ABSTRACT

Kratom is a legal, widely available substance that contains opioid agonist alkaloids. Due to the marketing of kratom as an opioid alternative for treatment of pain, anxiety, depression, or to reduce opioid withdrawal symptoms, the use of kratom has increased among persons in the USA including pregnant women. This systematic review of the peer-reviewed literature regarding kratom in relation to maternal and infant outcomes resulted in analysis of six case reports of prenatal kratom exposure. Maternal and infant withdrawal from kratom exposure was described in each case, resulting in pharmacologic treatment for both mothers and infants.


Subject(s)
Mitragyna , Prenatal Exposure Delayed Effects , Humans , Infant, Newborn , Mothers , Peer Review , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...